Presentations & Webinars

CD33 Program Expansion: Actimab-A + CLAG-M Conference Call

Feb 13, 2018

ASH 2017 Actimab-A Preliminary Phase 2 Results

Dec 14, 2017

ASH 2017 AWE Platform Results with Daratumumab

Dec 14, 2017

Webcast to Introduce New Clinical Initiative in Collaboration with Leading Hematologist Dr. Gail Roboz

Dec 5, 2017

Webinar Focused on Actimab-A and Recent Developments Related to CD33 Targeted AML Therapies

Jul 13, 2017

Webinar to Provide Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-B

Jun 12, 2017

Regulatory Perspective: Acute Leukemia Clinical Endpoints

Aug 2, 2016

• « Previous
• 1
• 2
• 3